Trials / Recruiting
RecruitingNCT06461260
Amygdala MRI-TIS for Depression
Safety, Efficacy and Neuroimaging Mechanisms of Amygdala Temporal Interference Stimulation Therapy for Depression
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study utilizes a non-invasive deep brain stimulation (temporal interference, TI) technique primarily targeting the amygdala to preliminarily explore the clinical efficacy and potential mechanisms of MRI-compatible TI technology in regulating the amygdala in depressive disorders, providing a more comprehensive basis for the application of TI technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nervio-X | An 8-channel TIS device developed by NEURODOME Corporation. |
Timeline
- Start date
- 2024-05-27
- Primary completion
- 2025-04-28
- Completion
- 2025-04-28
- First posted
- 2024-06-14
- Last updated
- 2024-06-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06461260. Inclusion in this directory is not an endorsement.